Pharmaceutical Executive artwork

Life Sciences · Pharmaceutical Executive Podcast

Pharmaceutical Executive

by Pharmaceutical Executive Podcast

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

Latest episodes

Showing 20 · updated from the feed

Pharmaceutical Executive Daily: FDA Approves Cosentyx and Wilserdly

Gilead signs royalty-free licensing deals to broaden Ebola antiviral access, FDA approves Cosentyx for polymyalgia rheumatica and Wilserdly for ESR1-mutated breast cancer

Nov 17
3 min

Pharmaceutical Executive Daily: FDA Approves Three New Therapies

#50 trending · Life Sciences

FDA approves three new therapies, a wave of dealmaking led by Johnson & Johnson, Eli Lilly, AmyriAD Therapeutics, and Sanofi, and Ossium Health’s Kevin Caldwell joins The

Nov 16
3 min

The Ron Lanton Report: Ossium Health's Bone Marrow Bank

Ossium Health’s Kevin Caldwell joins The Ron Lanton Report to explain how banked, deceased-donor marrow is replacing a months-long search for a living donor with a produc

Nov 16
23 min

Pharmaceutical Executive Daily: FDA Shelves CNPV Program

FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation

Nov 13
1 min

Pharmaceutical Executive Daily: Moderna Outlines Growth Plan at 2026 Analyst Day

Moderna lays out an oncology-driven growth plan at its 2026 Analyst Day, Pfizer and Blackstone sign a co-funding deal worth up to $1.5 billion for berobenatide, and Parex

Nov 12
2 min

Pharmaceutical Executive Daily: FDA Approves Pimjetmi

FDA approves Merck KGaA’s Pimjetmi for tenosynovial giant cell tumor, Parexel’s Stacy Hurt on when patient input should enter the clinical research process, and Ignite Pr

Nov 11
2 min

Pharmaceutical Executive Daily: FDA Requires Safety Label Update on GLP-1 Receptor Agonist

FDA approves Bayer’s asundexian as the first Factor XIa inhibitor for secondary stroke prevention, the FDA requires a new safety label warning across all GLP-1 receptor a

Nov 10
2 min

Pharmaceutical Executive Daily: argenx Acquires Unnatural Products Inc.

argenx acquires Unnatural Products for up to $1.15 billion to expand its immunology capabilities, GiftHealth’s Chip Parkinson on how single-partner platforms can transfor

Nov 9
2 min

Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Rybrevant Faspro

Hims & Hers partners with Eli Lilly to sell Zepbound and Foundayo directly on its platform, Novo Nordisk terminates its research collaboration with Korro Bio, and the FDA

Nov 6
2 min

Pharmaceutical Executive Daily: Egetis Sells Priority Review Voucher for $190 Million

ANI Pharmaceuticals makes an offer to acquire Egetis Therapeutics as Egetis separately sells its priority review voucher for $190 million, Novartis exits its BrainTranspo

Nov 5
2 min

Pharmaceutical Executive Daily: Nxera Licenses EP4 Agonist to AbbVie

How microgravity is opening new possibilities for drug R&D and manufacturing, a pharma funding roundup covers Boehringer Ingelheim’s up-to-$7 billion oncology licensing d

Nov 4
2 min

Pharmaceutical Executive Daily: FDA Approves Voceryq

FDA grants accelerated approval to INOVIO’s Voceryq to reduce surgical burden in recurrent respiratory papillomatosis, Brox.AI’s Hamish Brocklebank on the three levels of

Nov 2
2 min

States Take Center Stage in the Drug Pricing Fight

In this episode of the Pharmaceutical Executive podcast, Scott LaGanga, executive vice president of state advocacy at PhRMA, discusses the expanding influence of state po

Nov 2
32 min

Pharmaceutical Executive Daily: Pathos AI Enters Collaboration with Bristol Myers Squibb

Bristol Myers Squibb discloses a patient death in its Phase I CAR-T multiple sclerosis trial, Pathos AI launches multi-year collaborations with Bristol Myers Squibb and T

Oct 26
2 min

The Ron Lanton Report: A Conversation with Dr. Nadine Zawadzki

Pharmaceutical and health economist Dr. Nadine Zawadzki, Senior Director, FTI Consulting joins the Ron Lanton Report to discuss how value is defined and measured across h

Oct 26
37 min

Pharmaceutical Executive Daily: Treasury Issues Notice to Add Biotech into Proposed COINS Act

Treasury proposes adding biotechnology to its Outbound Investment Security Program, a pharma funding roundup covers Gilead’s $1.275 billion acquisition of an oral IL-23R

Oct 23
2 min

Building Biopharma Manufacturing for Speed, Scale, and Flexibility

Biopharma manufacturing today is being asked to move faster, accommodate increasingly complex modalities, and respond more readily to changing development timelines and d

Oct 23
37 min

Pharmaceutical Executive Daily: FDA Grants Ultomiris Accelerated Approval in the U.S.

FDA grants Ultomiris accelerated approval for primary immunoglobulin A nephropathy, a pharma funding roundup covers Alcon’s $550 million acquisition of Neurotech and AI P

Oct 22
2 min

Pharmaceutical Executive Daily: FDA Approves Hibsago

A new ICER and West Health report finds median drug launch prices climbed to $257,000, the FDA approves GSK’s Hibsago as the first functional-cure therapy for chronic hep

Oct 21
2 min

Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Jemperli

METiS TechBio and Eli Lilly collaborate on next-generation LNP delivery technology, Incubate’s John Stanford on how MFN deals may shape future pharma decisions, and the F

Oct 20
2 min

Chart trend

Position in the Life Sciences chart (US), last 90 days.

#18
all-time peak
98
days in the top 50 since Nov 2024

Chart positions

Where Pharmaceutical Executive ranks today in each Apple Podcasts chart (US, Nov 18, 2026).

#55 ▲ 20 Life Sciences US

More podcasts like Pharmaceutical Executive

Popular shows in Life Sciences, for your next listen.

Browse charts by category

Daily updated Apple Podcasts rankings for the United States.

About Pharmaceutical Executive on Reason.fm

Here you find the Apple Podcasts chart positions of Pharmaceutical Executive, its latest episodes to listen to directly, and reviews from listeners. Rankings are updated daily for the United States.

Contact

Questions or issues? Reach us at hello@reason.fm

0:000:00